Clinical & translational oncology

• 

  Año 2020, Vol. 22, Número 7

  • Review Article

    • Therapeutic potential of natural products in glioblastoma treatment:: targeting key glioblastoma signaling pathways and epigenetic alterations

      M.N. Abbas, S. Kausar, H. Cui

      • Resumen

      págs. 963-977

      

    • Li–Fraumeni syndrome heterogeneity

      P. Gargallo, Y. Yáñez, Vanessa Segura, A. Juan Ribelles, Antonio José Torres García, Julia Balaguer Guill, Juan Silvestre Oltra Soler, Victoria Castel Sánchez, María Adela Cañete Nieto

      • Resumen

      págs. 978-988

      

  • Special Article

    • Updated guidelines for predictive biomarker testing in advanced non‑small‑cell lung cancer:: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

      María Pilar Garrido López, E. Conde Gallego, José Enrique Castro Gómez, José Javier Gómez Román, Enriqueta Felip Font, Lara Pijuán Andújar, Dolores Isla Casado, Julián Sanz Ortega, Luis Paz-Ares Rodríguez, Fernando López-Rios Moreno

      • Resumen

      págs. 989-1003

      

  • Research Article

    • Prognostic factors associated with survival in a large cohort of gastric cancer patients resected over a decade at a single Italian center:: the Cremona experience

      M. Ghidini, L. Donis, L. Totaro, M. Ratti, C. Pizzo, I. Benzoni, D. Lomiento, F. Aldighieri, L. Toppo, V. Ranieri, C. Senti, G. Tanzi, M. Martinotti, R. Passalacqua, M. Rovatti, G. Tomasello

      • Resumen

      págs. 1004-1012

      

    • Baicalein, an enteric microbial metabolite, suppresses gut inflammation and cancer progression in ApcMin/+ mice

      C.Z. Wang, C.-F. Zhang, Y. Luo, H. Yao, C. Yu, L. Chen, J. Yuan, W.-H. Huang, J.-Y. Wan, J. Zeng, W.R. Sawadogo, C.-S. Yuan

      • Resumen

      págs. 1013-1022

      

    • Calcium‑sensing receptor bridges calcium and telomerase reverse transcriptase in gastric cancers via Akt

      R. Xie, B. Tuo, S. Yang, X.Q. Chen, J. Xu

      • Resumen

      págs. 1023-1032

      

    • Role of novel hormonal therapies in the management of non‑metastatic castration‑resistant prostate cancer:: a literature‑based meta‑analysis of randomized trials

      G. Roviello, M. Rong, A. Angelo, S. Nobili, E. Mini

      • Resumen

      págs. 1033-1039

      

    • Cross‑talk between ribosome biogenesis, translation, and mTOR in CD133+ 4/CD44+ prostate cancer stem cells

      Z. Binal, E. Açıkgöz, F. Kızılay, G. Öktem, B. Altay

      • Resumen

      págs. 1040-1048

      

    • Situation, challenges, and SEOM recommendations for the future of undergraduate education in Oncology in Spain

      Miguel Ángel Seguí Palmer, Juan Jesús Cruz Hernández, Emilio Alba, Jaime Feliu Batlle, Carlos Jara Sánchez, Fernando Rivera Herrero, Álvaro Rodríguez Lescure, A. Lorenzo, Miguel Martín Jiménez

      • Resumen

      págs. 1049-1058

      

    • Tumor‑infiltrating and circulating granulocytic myeloid‑derived suppressor cells correlate with disease activity and adverse clinical outcomes in mycosis fungoides

      K.V. Argyropoulos, Robert M Politzer, S. Perez, P. Korkolopoulou, Matina V. Angelopoulou, C. Baxevanis, M.L. Palomba, M. Siakantaris

      • Resumen

      págs. 1059-1068

      

    • Prognostic value of peptidyl‑prolyl cis–trans isomerase 1 (PIN1) in human malignant tumors

      S.G. Khoei, C. Mohammadi, Y. Mohammadi, S. Sameri, R. Najafi

      • Resumen

      págs. 1068-1077

      

    • Effects of radiotherapy on plasma energy metabolites in patients with breast cancer who received neoadjuvant chemotherapy

      Meritxell Arenas Prat, S. Fernández Arroyo, E. Rodríguez Tomàs, S. Sabater, Y. Murria, M. Gascón, K. Amillano, Mireia Mele, J. Camps, Jorge Joven Maried

      • Resumen

      págs. 1078-1085

      

    • Vitexin, an inhibitor of hypoxia‑inducible factor‑1α, enhances the radiotherapy sensitization of hyperbaric oxygen on glioma

      T. Xie, J.R. Wang, C.G. Dai, X.A. Fu, J. Dong, H.-Q. Huang

      • Resumen

      págs. 1086-1093

      

    • Multiple antibodies targeting tumor‑specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models

      N. K. Shukla, S.C. Pero, Y.J. Sun, L. Mei, F. Zhang, G. Sholler, D.N. Krag

      • Resumen

      págs. 1094-1104

      

    • Novel exosomal miR‑46146 transfer oxaliplatin chemoresistance in colorectal cancer

      Y. Xu, M. Zhu

      • Resumen

      págs. 1105-1116

      

    • Paradoxical prognostic phenomenon of plasma T‑cell‑derived circulating DNA level in advanced non‑small cell lung cancer

      P. Sitthideatphaiboon, S. Santisukwongchote, S. Khunsri, C. Sathitruangsak, P. Chantranuwat, C. Vinayanuwattikun, V. Sriuranpong

      • Resumen

      págs. 1117-1125

      

    • PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer

      H. Igarashi, H. Taniguchi, K. Nosho, K. Ishigami, Hiroshi Koide, K. Mitsuhashi, K. Akita, I. Takemasa, H. Imai, H. Nakase

      • Resumen

      págs. 1126-1137

      

    • Ganoderic acid A/DM‑induced NDRG2 over‑expression suppresses high‑grade meningioma growth

      A. Das, M. Alshareef, F. Henderson Jr., J.L. Martinez Santos, W.A. Vandergrift III, S.M. Lindhorst, A.K. Varma, L.K. Infinger, S.J. Patel, D. Cachia

      • Resumen

      págs. 1138-1145

      

    • The efficacy and safety of immune checkpoint inhibitors in non‑small cell lung cancer patients of different age groups: a meta‑analysis

      S.Y. Zheng, H.J. Cui, H. Duan, Y.M. Peng, Q. Li, C.Y. Sun, J. Y. Zhang, W. Shen, X. Zhang, K. Tan, X. Jiang

      • Resumen

      págs. 1146-1154

      

    • Dual‑targeted therapeutic strategy combining CSC–DC‑based vaccine and cisplatin overcomes chemo‑resistance in experimental mice model

      N. E. El-Ashmawy, M.L. Salem, E.G. Khedr, E. A. El-Zamarany, A.O. Ibrahim

      • Resumen

      págs. 1155-1165

      

    • HLA‑G as a new tumor biomarker: detection of soluble isoforms of HLA‑G in the serum and saliva of patients with colorectal cancer

      A.D. Lázaro Sánchez, P. Salces Ortiz, L.I. Velásquez, Domingo Luís Orozco Beltrán, N. Díaz Fernández, Asunción Juárez Marroquí

      • Resumen

      págs. 1166-1171

      

    • The prognostic role of FZD6 in esophageal squamous cell carcinoma patients

      J. Zhang, J.L. Wang, C.Y. Zhang, Y.F. Ma, R. Zhao, Y.Y. Wang

      • Resumen

      págs. 1172-1179

      

    • Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM)

      Patricia Saez Carlin, Alejandra García Botella, Luis Díez Valladares, Luis Ortega Medina, R. Méndez Colino, J.C.M. González, I. Bernal, I. Serrano García, R. Abellana, Antonio José Torres García

      • Resumen

      págs. 1180-1186

      

    • Spanish validation of Charlson index applied to prostate cancer

      Francesc Casas, Izaskun Valduvieco Ruiz, G. Oses, K. S. Cortés, T. Barreto, D. Muñoz, Ferran Ferrer González

      • Resumen

      págs. 1187-1192

      

    • Constitutive expression of c‑REL in uveal melanoma patients: correlation with clinicopathological parameters and patient outcome

      M.K. Singh, L. Singh, N. Pushker, K. Chodsol, S. Bakhshi, R. Meel, S. Sen, S. Kashyap

      • Resumen

      págs. 1193-1204